Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatology | 3 | 2021 | 86 | 1.020 |
Why?
|
| Panniculitis | 1 | 2021 | 2 | 0.750 |
Why?
|
| Vascular Malformations | 2 | 2018 | 47 | 0.690 |
Why?
|
| Glomus Tumor | 1 | 2017 | 2 | 0.580 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2017 | 6 | 0.580 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 22 | 0.560 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 1 | 2016 | 6 | 0.560 |
Why?
|
| Telemedicine | 2 | 2021 | 663 | 0.540 |
Why?
|
| Psoriasis | 1 | 2016 | 74 | 0.530 |
Why?
|
| Laser Therapy | 1 | 2017 | 100 | 0.520 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 144 | 0.510 |
Why?
|
| Inflammasomes | 1 | 2016 | 115 | 0.500 |
Why?
|
| Dinoprost | 1 | 2023 | 31 | 0.230 |
Why?
|
| Abdomen | 1 | 2021 | 100 | 0.180 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 123 | 0.180 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2021 | 93 | 0.180 |
Why?
|
| Mutation, Missense | 1 | 2021 | 295 | 0.170 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 73 | 0.160 |
Why?
|
| Autophagy | 1 | 2021 | 233 | 0.160 |
Why?
|
| Skin Diseases | 1 | 2020 | 122 | 0.160 |
Why?
|
| Lung Injury | 1 | 2021 | 197 | 0.160 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 307 | 0.160 |
Why?
|
| Irritants | 1 | 2018 | 41 | 0.150 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2018 | 66 | 0.150 |
Why?
|
| Waiting Lists | 1 | 2019 | 211 | 0.150 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2018 | 63 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 505 | 0.150 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 664 | 0.150 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 212 | 0.150 |
Why?
|
| ras Proteins | 1 | 2018 | 138 | 0.140 |
Why?
|
| Sweet Syndrome | 1 | 2016 | 7 | 0.140 |
Why?
|
| Mutation | 2 | 2018 | 3349 | 0.140 |
Why?
|
| Acne Vulgaris | 1 | 2016 | 20 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 276 | 0.130 |
Why?
|
| Eczema | 1 | 2016 | 81 | 0.130 |
Why?
|
| Pain | 1 | 2021 | 710 | 0.120 |
Why?
|
| Alleles | 1 | 2018 | 791 | 0.120 |
Why?
|
| Child | 5 | 2021 | 18350 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2021 | 12512 | 0.120 |
Why?
|
| Adolescent | 4 | 2021 | 17808 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 1319 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2321 | 0.100 |
Why?
|
| Humans | 9 | 2022 | 114714 | 0.100 |
Why?
|
| Pediatrics | 1 | 2019 | 983 | 0.100 |
Why?
|
| Infant | 3 | 2022 | 7934 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2016 | 723 | 0.090 |
Why?
|
| Phenotype | 1 | 2018 | 2811 | 0.090 |
Why?
|
| Male | 5 | 2022 | 55558 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2017 | 9079 | 0.060 |
Why?
|
| Population Dynamics | 1 | 2023 | 128 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 453 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2022 | 208 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 271 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 262 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 102 | 0.040 |
Why?
|
| Female | 4 | 2020 | 59485 | 0.040 |
Why?
|
| Philadelphia | 1 | 2019 | 46 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 838 | 0.040 |
Why?
|
| Play and Playthings | 1 | 2018 | 30 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2021 | 322 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 737 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 89 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 413 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 14916 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1370 | 0.030 |
Why?
|
| Animals | 3 | 2023 | 31761 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 593 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 912 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 2538 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 411 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 659 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 763 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 4899 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6216 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 9089 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 30543 | 0.010 |
Why?
|